BOD (psychedelic)
Names | |
---|---|
IUPAC name
2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethanamine | |
Other names
4-Methyl-2,5,β-trimethoxyphenethylamine 2-(4-Methyl-2,5,β-trimethoxyphenyl)ethanamine | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
| |
| |
Properties | |
C12H19NO3 | |
Molar mass | 225.28 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
BOD, or 4-methyl-2,5,beta-trimethoxyphenethylamine, is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-D. BOD was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–25 mg, and the duration listed as 8–16 hours. BOD produces strongly distorted open-eye visuals, and some closed-eye visuals. It also has an entheogenic effect and produces humor.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOD.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
See also
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.